Manufacturers Life Insurance Company, The Aeglea Bio Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $5,839 - $31,066	-11,679 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.87 - $4.77 $21,839 - $55,708	11,679 New	11,679 $26,000
Q1 2022 May 20, 2022	SELL	$1.87 - $4.77 $15,820 - $40,354	-8,460 Reduced 42.01%	11,679 $27,000
Q4 2021 Feb 16, 2022	SELL	$3.5 - $8.42 $18,144 - $43,649	-5,184 Reduced 20.47%	20,139 $96,000
Q3 2021 Nov 12, 2021	SELL	$6.03 - $7.95 $7,236 - $9,540	-1,200 Reduced 4.52%	25,323 $201,000
Q2 2021 Aug 12, 2021	SELL	$6.32 - $8.38 $16,267 - $21,570	-2,574 Reduced 8.85%	26,523 $185,000
Q1 2021 May 03, 2021	SELL	$6.76 - $8.57 $182 - $231	-27 Reduced 0.09%	29,097 $230,000
Q4 2020 Feb 12, 2021	BUY	$7.02 - $9.83 $23,657 - $33,127	3,370 Added 13.09%	29,124 $229,000
Q2 2020 Aug 10, 2020	BUY	$4.01 - $11.04 $28,755 - $79,167	7,171 Added 38.59%	25,754 $236,000
Q1 2020 May 15, 2020	BUY	$3.51 - $8.48 $4,159 - $10,048	1,185 Added 6.81%	18,583 $87,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $8.55 $16,079 - $19,015	-2,224 Reduced 11.33%	17,398 $133,000
Q3 2019 Nov 12, 2019	BUY	$6.42 - $9.0 $616 - $864	96 Added 0.49%	19,622 $150,000
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $119,108 - $171,438	19,526 New	19,526 $134,000
Q3 2018 Nov 14, 2018	SELL	$8.24 - $11.0 $113,341 - $151,305	-13,755 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $108,251 - $149,791	13,755 New	13,755 $145,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.